Items where Author is "Jeyabalan, J"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 5.

Article

Pereira, M and Jeyabalan, J and Jorgensen, C S and Hopkinson, M and Al-Jazzar, A and Roux, J P and Chavassieux, P and Orriss, I R and Cleasby, M E and Chenu, C (2015) Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice. BONE, 81. pp. 459-67.

Jeyabalan, J and Viollet, B and Smitham, P and Ellis, S A and Zaman, G and Bardin, C and Goodship, A and Roux, J P and Pierre, M and Chenu, C (2013) The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing. OSTEOPOROSIS INTERNATIONAL, 24 (10). p. 2659.

Jeyabalan, J and Shah, M and Viollet, B and Chenu, C (2012) AMP-activated protein kinase pathway and bone metabolism. JOURNAL OF ENDOCRINOLOGY, 212 (3). pp. 277-290.

Jeyabalan, J and Shah, M and Viollet, B and Roux, J P and Chavassieux, P and Korbonits, M and Chenu, C (2012) Mice lacking AMP-activated protein kinase alpha 1 catalytic subunit have increased bone remodeling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment. JOURNAL OF ENDOCRINOLOGY, 214 (3). pp. 349-358.

Conference or Workshop Item

Jeyabalan, J and Viollet, B and Smitham, P and Undre, Y and Ellis, S A and Goodship, A and Chenu, C (2012) THE ANTI-DIABETIC DRUG METFORMIN HAS NO DELETERIOUS EFFECT ON BONE MASS IN VIVO BUT DOES NOT INDUCE OSTEOGENESIS NOR FRACTURE HEALING. In: UNSPECIFIED.

This list was generated on Wed May 12 07:22:36 2021 BST.